Acebrophylline 200mg Sustained Release
Acebrophylline 200mg SR — same dual bronchodilator-mucolytic molecule as SAFEBRO 100, at double the dose in a sustained-release formulation. The SR tablet releases Acebrophylline gradually over 12 hours, maintaining steady therapeutic levels throughout the day with twice-daily dosing. This avoids the peak-trough fluctuations of immediate-release formulations that can cause side effects at peaks and lose efficacy at troughs.
Moderate-to-severe COPD requiring higher bronchodilator dose, chronic bronchitis in elderly patients needing once or twice-daily dosing, and respiratory conditions where sustained airway opening and mucus clearance throughout the day is important.
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
The SR formulation at 200mg is the preferred option for moderate-severe COPD and elderly patients where compliance and consistent 24-hour airway control matter most.
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.